Company / Net Debt per Share
Abbott Laboratories Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$2.52
FY2025
5-year range
$2.52 / $4.63
FY2021-FY2025
Trend
-31.7%
vs FY2024
Sector context
#65 of 98
Health Care
What the data says
At $2.52, Abbott Laboratories's net debt per share ranks #34 of 98 in the Health Care sector. Net Debt per Share has fluctuated over the past 10 years, ranging from $2.52 in FY2025 to $12.16 in FY2017.
Based on SEC 10-K filings.
2.52 in FY2025 with a 5-year CAGR of -17.5%.
Improved from $4.35 to $2.52 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -13.2%
- 5-Year CAGR
- -17.5%
- 10-Year CAGR
- -
Sector benchmark
#34 of 98 in Health CareTop 34% of 98This company $2.52 Sector average $7.39
▼
-65.9% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 31.7% year-over-year.
- Ranks #65 out of 98 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2017.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.52 | -31.7% |
| FY2024 | $3.69 | -15.2% |
| FY2023 | $4.35 | +12.8% |
| FY2022 | $3.86 | -16.7% |
| FY2021 | $4.63 | -29.9% |
| FY2020 | $6.61 | -17.9% |
| FY2019 | $8.05 | -23.1% |
| FY2018 | $10.47 | -13.9% |
| FY2017 | $12.16 | +11.7% |
| FY2016 | $10.88 | +614.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026